Farhad Ravandi Selected Research

Farhad Ravandi Research Topics

Disease

253	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 02/2004
89	Neoplasms (Cancer) 03/2024 - 02/2005
83	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024 - 02/2006
81	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 06/2006
66	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 11/2002
63	Leukemia 12/2023 - 11/2002
59	Philadelphia Chromosome 04/2024 - 09/2006
35	Acute Promyelocytic Leukemia 02/2024 - 02/2004
22	Infections 11/2023 - 02/2005
21	Residual Neoplasm 12/2022 - 01/2009
17	Hairy Cell Leukemia 05/2024 - 09/2005
15	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2024 - 10/2006
13	Blast Crisis (Blast Phase) 01/2023 - 02/2007
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 02/2005
13	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2003
12	Exanthema (Rash) 11/2023 - 06/2009
11	Thrombocytopenia (Thrombopenia) 01/2023 - 07/2010
11	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 09/2006
10	Neutropenia 04/2024 - 05/2004
10	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 06/2011
10	Pathologic Complete Response 12/2020 - 09/2010
8	Disease Progression 05/2024 - 10/2012
8	Hypertension (High Blood Pressure) 01/2023 - 01/2011
7	Lymphoma (Lymphomas) 01/2021 - 04/2006
6	Anemia 01/2023 - 07/2010
6	Fatigue 12/2021 - 05/2006
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 03/2003
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 08/2013
5	Nausea 11/2023 - 02/2015
5	Hemorrhage 01/2023 - 06/2009
5	Diarrhea 01/2019 - 10/2008
4	Leukocytosis (Pleocytosis) 01/2022 - 09/2008
4	Hyperbilirubinemia 01/2022 - 10/2008
4	Pneumonia (Pneumonitis) 01/2022 - 07/2012

Drug/Important Bio-Agent (IBA)

55	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 11/2005
53	Tyrosine Kinase InhibitorsIBA 01/2023 - 05/2009
45	venetoclaxIBA 04/2024 - 01/2018
44	Decitabine FDA Link 04/2024 - 03/2003
34	Imatinib Mesylate (Gleevec)FDA Link 11/2019 - 02/2003
28	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 10/2007
24	Dasatinib (BMS 354825)FDA Link 04/2024 - 08/2008
22	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 12/2008
19	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 10/2008
18	Arsenic Trioxide (Trisenox)FDA Link 02/2024 - 11/2002
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2002
17	ponatinibIBA 04/2024 - 04/2015
17	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2024 - 02/2004
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 03/2003
16	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 02/2007
16	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 10/2008
16	Monoclonal AntibodiesIBA 01/2021 - 09/2005
16	Clofarabine (Clolar)FDA Link 01/2021 - 07/2006
15	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2011
14	blinatumomabIBA 12/2023 - 01/2018
14	Inotuzumab OzogamicinIBA 12/2023 - 06/2013
13	Rituximab (Mabthera)FDA Link 05/2024 - 08/2010
13	Phosphotransferases (Kinase)IBA 01/2023 - 11/2002
13	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 10/2008
12	Cladribine FDA LinkGeneric 05/2024 - 06/2006
12	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 12/2008
11	fludarabineIBA 01/2023 - 12/2008
11	NucleosidesIBA 12/2015 - 09/2005
9	Transaminases (Aminotransferases)IBA 01/2023 - 10/2008
9	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 02/2009
8	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 08/2013
8	BilirubinIBA 12/2023 - 04/2012
8	Lenalidomide (CC 5013)FDA Link 10/2022 - 10/2009
8	purineIBA 05/2022 - 09/2005
8	Alemtuzumab (Campath)FDA Link 11/2009 - 02/2005
7	NucleophosminIBA 01/2023 - 01/2009
7	AnthracyclinesIBA 05/2022 - 07/2010
7	ruxolitinibIBA 11/2021 - 08/2011
7	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 03/2014
7	Pentostatin (Nipent)FDA LinkGeneric 01/2020 - 01/2006
7	Prednisone (Sone)FDA LinkGeneric 12/2018 - 10/2009
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 10/2013
6	CreatinineIBA 12/2023 - 01/2010
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 12/2008
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2011
6	Tyrosine (L-Tyrosine)FDA Link 10/2019 - 01/2008
6	vosaroxinIBA 11/2018 - 02/2015
6	nilotinib FDA Link 01/2018 - 08/2008
5	EnzymesIBA 01/2023 - 08/2010
5	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 12/2011
5	Methotrexate (Mexate)FDA LinkGeneric 02/2016 - 04/2007
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2010

Therapy/Procedure

222	Therapeutics 04/2024 - 02/2003
108	Drug Therapy (Chemotherapy) 05/2024 - 02/2006
21	Stem Cell Transplantation 01/2023 - 02/2005
16	Induction Chemotherapy 01/2022 - 12/2010
14	Salvage Therapy 01/2023 - 07/2007
13	Hematopoietic Stem Cell Transplantation 01/2023 - 05/2006
6	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 11/2010
5	Cell Transplantation 11/2022 - 01/2007
5	Immunotherapy 01/2022 - 06/2011
5	Transplantation 01/2021 - 11/2006
4	Consolidation Chemotherapy 12/2022 - 01/2018
4	Remission Induction 10/2022 - 01/2010
4	Radiotherapy 10/2022 - 02/2012